isoxazoles has been researched along with Psoriasis Arthropathica in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 25 (62.50) | 29.6817 |
2010's | 15 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahern, MJ; Barbara, JA; Russo, PA; Shanahan, EM; Smith, MD; Wiese, MD | 1 |
Orr, C; Veale, DJ | 1 |
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
Dejaco, C; Duftner, C; Ficjan, A; Graninger, WB; Gretler, J; Gutierrez, M; Hermann, J; Husic, R; Lackner, A | 1 |
Al-Mossawi, MH; Bowness, P; Brennan, PE; de Wit, J; Fedorov, O; Hammitzsch, A; Hay, DA; Knapp, S; Martinez, FO; Müller, S; O'Mahony, A; Tallant, C; Vecellio, M; Wells, C; Wordsworth, P | 1 |
Avcin, T; Calonje, E; Luzar, B; Vesel, T | 1 |
Beukelman, T; Cassell, S; Curtis, JR; Greenberg, JD; Kavanaugh, A; Kremer, JM; Onofrei, A; Reed, G; Strand, V | 1 |
Abdelmoula, LC; Ben M'Barek, R; Chaabouni, L; Tekaya, R; Testouri, N; Yahia, CB; Zouari, R | 1 |
Cantagrel, A; Claudepierre, P; Combe, B; Dernis, E; Flipo, RM; Gaudin, P; Goupille, P; Lavie, F; Le Loët, X; Maillefert, JF; Paul, C; Salliot, C; Saraux, A; Schaeverbeke, T; Tebib, J; Wendling, D | 1 |
Alivernini, S; Ferraccioli, G; Mazzotta, D; Zoli, A | 1 |
Callado, MR; Vieira, FJ; Vieira, WP | 1 |
Huang, F; Li, XF; Zhang, GL; Zhang, JL | 1 |
Hutchinson, DG; Lee, MA | 1 |
Matuszewska, A; Misterska-Skóra, M; Wiland, P | 1 |
Boulinguez, S; Goupille, P; Passeron, T | 1 |
Anić, B; Babić-Naglić, D; Grazio, S; Martinavić Kaliterna, D; Novak, S | 1 |
Jagoda, JS; Rajapakse, CN | 1 |
Lubrano, E; Scarpa, R | 1 |
Behrens, F; Burkhardt, H; Finkenwirth, C; Pavelka, K; Šipek-Dolnicar, A; Štolfa, J; Thaçi, D | 1 |
Anastasilakis, AD; Kapetanos, GA; Sakellariou, GT; Sayegh, FE | 1 |
Cuchacovich, M; Soto, L | 1 |
Fantini, F | 1 |
Behrens, F; Falk, FG; Gladman, D; Jones, P; Kaltwasser, JP; Mease, P; Nash, P; Rosen, CF; Wollenhaupt, J | 1 |
Gladman, DD | 1 |
Garg, G; Thami, GP | 1 |
Braun, J; Haibel, H; Rudwaleit, M; Sieper, J | 1 |
Chandler, D; Griffiths, CE; Helliwell, P; Kyle, S; Lewis, J; McHugh, N; McInnes, I; Oliver, S; Symmons, D | 1 |
Schmitt, J; Wozel, G | 1 |
Goupille, P | 1 |
Behrens, F; Falk, F; Kaltwasser, JP; Nash, P; Thaçi, D | 1 |
Braun, J; Sieper, J | 1 |
Choy, EH; Ravindran, V; Scott, DL | 1 |
McHugh, NJ; Soriano, ER | 1 |
Kaltwasser, JP | 1 |
Denisov, LN; Godzenko, AA; Korotaeva, TV; Korsakova, IuL; Pchelintseva, AO; Stanislav, ML | 1 |
Delaporte, E; Delesalle, F; Gautier, S; Gros, C | 1 |
Bagot, M; Claudepierre, P | 1 |
Bodur, H; Ergül, G; Eser, F; Seçkin, S; Seçkin, U | 1 |
Beckmann, I; Hummel, KM; Mössner, R; Neumann, C; Reich, K | 1 |
9 review(s) available for isoxazoles and Psoriasis Arthropathica
Article | Year |
---|---|
[Update in treatment of psoriatic arthritis].
Topics: Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Dermatologic Agents; Humans; Isoxazoles; Leflunomide; Recombinant Fusion Proteins; Tumor Necrosis Factor-alpha | 2008 |
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Cyclosporine; Evidence-Based Medicine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Multicenter Studies as Topic; Nails; Skin; Sulfasalazine | 2012 |
[New drugs and treatment strategies for rheumatoid arthritis].
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Etanercept; Follow-Up Studies; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Isoxazoles; Leflunomide; Middle Aged; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Time Factors; Tumor Necrosis Factor-alpha | 2003 |
Psoriatic arthritis.
Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Etanercept; Gold Sodium Thiomalate; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sulfasalazine; Tumor Necrosis Factor Decoy Receptors | 2004 |
Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
Topics: Algorithms; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Psoriatic arthritis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Etanercept; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2005 |
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.
Topics: Alefacept; Antirheumatic Agents; Arthritis, Psoriatic; Biological Products; Humans; Isoxazoles; Leflunomide; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Risk Assessment; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
Conventional therapy of psoriatic arthritis: evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome | 2007 |
Leflunomide in psoriatic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Humans; Isoxazoles; Leflunomide | 2007 |
6 trial(s) available for isoxazoles and Psoriasis Arthropathica
Article | Year |
---|---|
[A clinical study of leflunomide and methotrexate therapy in psoriatic arthritis].
Topics: Adult; Arthritis, Psoriatic; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Treatment Outcome | 2009 |
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
Topics: Adult; Aged; Arthritis, Psoriatic; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Placebos; Quality of Life; Treatment Outcome | 2004 |
Leflunomide in psoriasis and psoriatic arthritis: a preliminary study.
Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Treatment Outcome | 2004 |
Six months open label trial of leflunomide in active ankylosing spondylitis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Patient Dropouts; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome | 2005 |
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Quality of Life; Skin | 2006 |
[Results of leflunomide treatment of psoriatic arthritis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Arthralgia; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Pain Measurement; Quality of Life; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2007 |
25 other study(ies) available for isoxazoles and Psoriasis Arthropathica
Article | Year |
---|---|
Leflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: a pharmacokinetic and pharmacogenetic study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cytochrome P-450 CYP2C19; Humans; Isoxazoles; Kidney Failure, Chronic; Leflunomide; Male; Neoplasm Proteins; Peritoneal Dialysis; Polymorphism, Single Nucleotide | 2013 |
Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Humans; Interleukin-12; Interleukin-17; Interleukin-23; Isoxazoles; Leflunomide; Methotrexate; Signal Transduction; Tumor Necrosis Factor-alpha; Ustekinumab | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score).
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Bone and Bones; Feasibility Studies; Female; Follow-Up Studies; Humans; Inflammation; Isoxazoles; Joints; Leflunomide; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Sulfasalazine; Surveys and Questionnaires; Synovial Membrane; Tendons; Time Factors; Ultrasonography, Doppler | 2014 |
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
Topics: Adult; Aged; Arthritis, Psoriatic; Azepines; Benzimidazoles; Calorimetry; CD4-Positive T-Lymphocytes; Cells, Cultured; Crystallography, X-Ray; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-17; Isoxazoles; Kinetics; Male; Middle Aged; Models, Molecular; Molecular Structure; p300-CBP Transcription Factors; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins; Spondylitis, Ankylosing; Structure-Activity Relationship; Th17 Cells; Triazoles | 2015 |
Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Infliximab; Isoxazoles; Leflunomide; Male | 2009 |
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Cohort Studies; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Young Adult | 2010 |
Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinion.
Topics: Advisory Committees; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Evidence-Based Medicine; Expert Testimony; Follow-Up Studies; Glucocorticoids; Hospitals, Teaching; Humans; Isoxazoles; Joints; Leflunomide; Placebos; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2009 |
Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Isoxazoles; Italy; Leflunomide; Male; Medication Adherence; Middle Aged; Retrospective Studies; Severity of Illness Index; Survival Rate; Treatment Outcome | 2009 |
Abatacept as an option therapy in difficult to treat psoriatic arthritis.
Topics: Abatacept; Arthritis, Psoriatic; Drug Administration Schedule; Drug Resistance; Female; Hepatitis; Humans; Immunoconjugates; Immunosuppressive Agents; Isoniazid; Isoxazoles; Joints; Leflunomide; Leg; Methotrexate; Middle Aged; Nucleic Acid Synthesis Inhibitors; Skin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
HRCT-proven leflunomide pneumonitis in a patient with psoriatic arthritis and normal lung function tests and chest radiography.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Middle Aged; Radiographic Image Enhancement; Respiratory Function Tests; Tomography, X-Ray Computed | 2010 |
[Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy].
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Contraindications; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications; Sulfasalazine | 2010 |
[Recommendations on the management of psoriatic arthritis].
Topics: Analgesics; Antirheumatic Agents; Arthritis, Psoriatic; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intra-Articular; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Tumor Necrosis Factor-alpha | 2011 |
[Treatment of rheumatoid and psoriatic arthritis--review of leflunomide].
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide | 2010 |
Leflunomide in clinical practice. A retrospective observational study on use of leflunomide in New Zealand.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Kaplan-Meier Estimate; Leflunomide; Male; Middle Aged; New Zealand; Retrospective Studies; Young Adult | 2011 |
Leflunomide in psoriatic arthritis: results from a large European prospective observational study.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Europe; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Disease Progression; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retreatment; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2013 |
Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Follow-Up Studies; Foot; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Radiography | 2002 |
Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Approval; France; Humans; Immunosuppressive Agents; Isoxazoles; Treatment Outcome | 2005 |
[Psoriasis arthritis--long-term treatment of two patients with leflunomide].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Longitudinal Studies; Middle Aged; Pain Measurement; Quality of Life; Treatment Outcome | 2004 |
[Spondylarthritides].
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Diagnostic Imaging; Etanercept; Female; HLA-B27 Antigen; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Physical Therapy Modalities; Receptors, Tumor Necrosis Factor; Spine; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine | 2006 |
[Leflunomide-induced skin necrosis].
Topics: Abdomen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Female; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Necrosis; Skin; Time Factors | 2008 |
[Psoriatic arthritis].
Topics: Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis | 2008 |
Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Colchicine; Drug Therapy, Combination; Familial Mediterranean Fever; Gout Suppressants; Health Status; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Male; Severity of Illness Index; Spondylarthropathies; Treatment Outcome | 2008 |
Treatment of severe psoriasis and psoriatic arthritis with leflunomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis | 2002 |